跳至主要内容
临床试验/NCT02866305
NCT02866305招募中早期 1 期

Thoracoscopic Treatment of Primary Pneumothorax - A National Randomised Controlled Trial

Odense University Hospital3 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
招募中
入组人数
300
试验地点
3
主要终点
Time to ipsilateral recurrence

研究概览

简要总结

Knowledge about incidence, risk factors and genetic predispositions of primary spontaneous pneumothorax in young adults is very limited, and treatment has also been controversial.The Aim of this study is to optimize the treatment, estimate the actual incidence, and identify possible risk factors including genetic predispositions.

详细描述

  • Background Knowledge about incidence, risk factors and genetic predispositions of primary spontaneous pneumothorax in young adults is very limited, and treatment has also been controversial. Typically, the first incidence is treated conservatively with simple chest tube drainage and only if the disease reoccurs is surgery considered. However, conventional treatment may be associated with increased morbidity, prolonged hospitalization and many young adults are concerned about the high recurrence of this disease. The latter has been reported in as many as 25-35% of patients. Because spontaneous pneumothorax in young adults usually is associated with apical blebs, the investigators hypothesized that primary surgery (Video-Assisted Thoracoscopic Surgery = VATS) with resection of such blebs at the time of the first episode of pneumothorax might be an effective first line treatment associated with lower morbidity and shorter hospital stays, and a definite decline in recurrence rate.
  • Method From July 2009 the investigators conducted a nationwide study , where 300 consecutive patients admitted to a Danish hospital with primary spontaneous pneumothorax undergo a high resolution CT of the thorax. Based upon the CT the patients are randomised to conventional conservative treatment (chest tube drainage) or primary VATS with bleb resection and mechanical pleurodesis.

Participants are followed for ten years. The primary endpoint is ipsilateral recurrence of pneumothorax. Secondary endpoints are length of hospitalization, duration of chest tube drainage and miscellaneous complications.

Simultaneously, a research biobank containing blood samples and pulmonary tissue is created for future studies of biomarkers and possible genetic causes.

Finally, the investigators are conducting a national epidemiological study, where the incidence in the Danish population is investigated.

*Perspective This study contributes new knowledge on incidence, genetics and best treatment of primary spontaneous pneumothorax in young adults which will have an impact on the future strategy of both understanding and treatment of this disease on a global level.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • First incidence of primary spontaneous pneumothorax.
  • Age between 18 and
  • No known preexisting pulmonary disease.
  • Patient must accept randomization.
  • Able to read and understand information regarding the study.
  • The condition must require treatment with a chest-tube.

排除标准

  • Age above
  • Previously pulmonary og cardiac surgery.
  • Pregnant or breastfeeding.
  • Patients who do not tolerate anesthetics.

研究组 & 干预措施

HRCT no bullae, treatment conservative

Experimental

Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.

干预措施: High-resolution Computer Tomography (Radiation)

HRCT with bullae, treatment conservative

Experimental

Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.

干预措施: Chest tube insertion (Procedure)

HRCT with bullae, treatment conservative

Experimental

Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.

干预措施: High-resolution Computer Tomography (Radiation)

HRCT no bullae, treatment conservative

Experimental

Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to conservative treatment with conventional chest-tube drainage.

干预措施: Chest tube insertion (Procedure)

HRCT with bullae, treatment VATS.

Experimental

Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

干预措施: VATS bullectomy and mechanical pleuradesis. (Procedure)

HRCT with bullae, treatment VATS.

Experimental

Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

干预措施: Chest tube insertion (Procedure)

HRCT with bullae, treatment VATS.

Experimental

Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

干预措施: Epidural (Drug)

HRCT with bullae, treatment VATS.

Experimental

Patients undergo High-resolution CT scan, and significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

干预措施: High-resolution Computer Tomography (Radiation)

HRCT no bullae, treatment VATS.

Experimental

Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

干预措施: VATS bullectomy and mechanical pleuradesis. (Procedure)

HRCT no bullae, treatment VATS.

Experimental

Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

干预措施: Chest tube insertion (Procedure)

HRCT no bullae, treatment VATS.

Experimental

Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

干预措施: Epidural (Drug)

HRCT no bullae, treatment VATS.

Experimental

Patients undergo High-resolution CT scan, and no significant bullae are identified (i.e. > 1 cm). Afterwards randomised to active treatment with VATS bullectomy and mechanical pleurodesis.

干预措施: High-resolution Computer Tomography (Radiation)

结局指标

主要结局

Time to ipsilateral recurrence

时间窗: 10 years

All participants are followed 10 years from the initial discharge via Questionnaires

次要结局

  • Number of Participants with Adverse Events as a Measure of Safety and Tolerability(10 years)
  • Length of hospital stay(up to 10 years)
  • Pain according to NRS scale reported at discharge, at 4 weeks, 1 year, 5 years and 10 years.(up to 10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Winnie Hedevang Olesen

MD and Principal investigator

Odense University Hospital

研究点 (3)

Loading locations...

相似试验